Size: px
Start display at page:

Download ""

Transcription

1 A Gay Men s Health Service Audit of: Post Exposure Prophylaxis Robert Obara, BSc MPH MBBChBAO Candidate, TCD Class of 2014 Poster for BASHIV, Dr Dominic Rowley (GMHS) et al.

2 PEP Talk Antiretroviral drugs (Truvada + Kaletra) Within 72 hours of HIV exposure Must be taken for 4 weeks Free of charge Side effects often experienced GMHS PEP Audits Main audit: July 2011 October 2011 Compiled demographics Evaluated clinical management Re-audit competed spring 2013

3 PEP Recipient Demographics } 52 PEP recipients were identified 31 from the first audit & 21 from the re-audit } All were MSM }

4 Reason for requesting PEP HIV Risk 13% (n=7) documented partner as HIV positive (3 of 7 documented partner taking HAART) Majority unaware of their partners status 27% (n=14) reported condom accidents No cases of non consensual sex were documented Majority were documented as consensual unprotected intercourse with a casual partner

5 1 st Clinical Review Findings 87% (n=27) had baseline HIV bloods documented 90% (n=29) received Truvada and Kaletra 77% (n=24) completed the full course Reasons for non-completion included discovery of partner HIV status, PEP side effect intolerance, anxiety, and limited HIV exposure 77% (n=24) had a 4 week follow-up HIV test 67% (n=21) had a 12 week test All 31 patients tested HIV negative at subsequent blood tests

6 Re-Audit of Clinical Practice 100% (n=21) had baseline HIV test 95% (n=20) had Hep B immunity status documented 90% (n=19) had Hep C result within the past 2 years Decrease in PEP prescriptions for insertive anal only No seroconversions were discovered Noted inconsistencies in the timing of follow up HIV tests (1 12 weeks) and lab tests (FBCs and LFTs) Thus standardized clinical protocol and patient leaflets

7 PatientInformationLeafletonPEPSE HighRiskPack Youarebeingstartedoncombinationanti viraldrugs.thisistohelppreventhiv afterpossiblesexualexposuretothehivvirus. Thedrugsintwoseparateproducts(colouredtablets)willbeprescribedforatotalof 28Days. Youhavereceivedan8daypack.YoumustattendyournextappointmentatGMHS toobtaintherestofthesupply,beforethe8daysupplyrunsout. Pleasetrynottomissanydoses.Ifyouforgettotakeadose,takeitassoonasyou rememberandthenextdoseatthenormaltime.nevertakeadoubledose. PleasecheckwithyourdoctorattheGMHSabouttakinganynewmedications (prescriptionornonprescription)whilstonthiscombinationtherapy. ContactTelephoneNumber:GMHS DateofPrescription: Doctor: Appointments&Procedures. 1 st Appointment:(7or8daysfromtoday): RestofTabletsandBloodTests:LFT/FBC/Renal. 2 nd Appointment:6WeeksfromprescriptionDate ST Is cre ena n dbl oo d Tes t s: (HIV,HEPC,Syphilis). 3 rd Appointment:12WeeksfromprescriptionDate: FinalBloodTests:(HIV,HEPC,Syphilis). DrugsDescription TRUVADA (BlueTablet) TakeisONEtabletperDAY,withfood. TheTRUVADA tabletcontains2differentdrugs Tenofovir(Ten)andEmtricitabine (FTC).Itisusuallywelltolerated. Possiblesideeffectsincludeachesandpains,dizziness,headaches,diarrhoea, nausea,vomitingandinsomnia.(therearetabletstohelpwiththisseebelow) KALETRA (PaleYellowTablet) TakeTWOtabletsTWICEaday(every12Hours),withorwithoutfood. TheactivedruginKaletra islopinavir.asmalldoseofanadditionaldrug,ritonavir, isincludedtoincreasethebloodlevelsoflopinavir. ThemostcommonsideaffectsofKALETRA arediarrhoeaandincreasedcholesterol. Headache,insomnia,gastrointestinaleffectsandchangesinbloodsugarsorliver enzymesmayalsooccur. TherearesomemedicationsthatcannotbetakenwhenonKALETRA Itisimportanttotellthedoctorandpharmacistaboutanyothermedications (prescriptionornonprescription)youarecurrentlytaking. Helpfulhints: (BLUEtablet:onceperday) (Pale/Yellowtablet:2twiceperdaymorningandevening) OthermedicationbelowtohelpyouwhiletakingPEP Thesecanbeboughtatachemistwithoutprescription Imodium2mgCapsules Anti DiarrhoeaTabletstotakeasneededdaily Motilium10mgTablets Anti NauseaTablets Take2tablets,30minutesbeforetheothertabletsprescribed.Morningandevening forthemonthasnecessary. Paracetamol(takeasdirectedonpack) Thisisasuitablepainkillertotakeforheadache,achesorpains

8

Prevention of transmission of HIV and other bloodborne viruses in healthcare and post exposure prophylaxis. John Ferguson, UPNG 2012

Prevention of transmission of HIV and other bloodborne viruses in healthcare and post exposure prophylaxis. John Ferguson, UPNG 2012 Prevention of transmission of HIV and other bloodborne viruses in healthcare and post exposure prophylaxis John Ferguson, UPNG 2012 Outline Epidemiology Making the diagnosis / contact tracing Antiretroviral

More information

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

HPTN 073: Black MSM Open-Label PrEP Demonstration Project HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers

More information

Getting to Know PrEP (Pre-Exposure Prophylaxis)

Getting to Know PrEP (Pre-Exposure Prophylaxis) (Pre-Exposure Prophylaxis) What is PrEP? Prep stands for Pre-Exposure Prophylaxis: a medication that was recently approved by the FDA for daily use that can help high-risk patients who are HIV negative

More information

POST EXPOSURE PROPHYLAXI S

POST EXPOSURE PROPHYLAXI S Departments of Infectious Diseases & Emergency Medicine POST EXPOSURE PROPHYLAXI S QUI CK GUI DE FOR EMERGENCY DEPT Adapted from Irish National PEP Guidelines and St James s Hospital GUIDE Clinic/Emergency

More information

NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS (npep)

NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS (npep) NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS (npep) Guidance from the Michigan Department of Health and Human Services Division of Health, Wellness & Disease Control Revised June 2015 The Michigan Department

More information

4/15/2010. Vermont Department of Health STD/HIV Program Vermont Department of Health STD/HIV Program. Vermont Department of Health STD/HIV Program

4/15/2010. Vermont Department of Health STD/HIV Program Vermont Department of Health STD/HIV Program. Vermont Department of Health STD/HIV Program First Let s Look at Some Numbers HIV Postexposure Prophylaxis for Occupational and Non- occupational Exposure National Vermont VtSHP Annual Meeting 4/10/10 Deborah Kutzko FNP "Financial support for this

More information

Pre-exposure prophylaxis (PrEP)

Pre-exposure prophylaxis (PrEP) FACTSHEET Pre-exposure prophylaxis (PrEP) Summary Pre-exposure prophylaxis, or PrEP, is a way for an HIV-negative person who is at risk of HIV infection to reduce their risk of becoming infected with HIV.

More information

GUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND

GUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND GUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND Revised February 2012 TABLE OF CONTENTS INTRODUCTION AND

More information

Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers

Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers James Wilton Coordinator, Biomedical Science of HIV Prevention

More information

POSTEXPOSURE PROPHYLAXIS

POSTEXPOSURE PROPHYLAXIS POSTEXPOSURE PROPHYLAXIS Bloodborne viruses Hepatitis B Hepatitis C HIV Hepatitis B Risk of seroconversion HBeAg negative 2% HBeAg positive 20-40% If seroconvert most recover completely and develop immunity

More information

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV

More information

HIV Guidelines. New Strategies.

HIV Guidelines. New Strategies. HIV Guidelines. New Strategies. Santiago Moreno Hospital Universitario Ramón y Cajal Madrid HIV Guidelines. New Strategies. Outline HIV Guidelines What is new? New strategies Treatment as Prevention HIV

More information

Hepatitis C. Screening, Diagnosis and Linkage to Care

Hepatitis C. Screening, Diagnosis and Linkage to Care Hepatitis C Screening, Diagnosis and Linkage to Care Diagnosis If your hepatitis C antibody test is reactive, a second test will be needed to diagnose and determine if you are currently infected. Screening

More information

HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016

HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually

More information

NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS. Carl LeBuhn, MD

NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS. Carl LeBuhn, MD NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS Carl LeBuhn, MD Post-Exposure Prophylaxis (PEP) The use of therapeutic agents to prevent infection following exposure to a pathogen

More information

POST EXPOSURE MANAGEMENT: HEPATITIS B, HEPATITIS C AND HIV

POST EXPOSURE MANAGEMENT: HEPATITIS B, HEPATITIS C AND HIV Middlesex-London Health Unit 50 King St. London, Ontario N6H 5M3 Phone: 519-663-5317 X 2330 After Hours: 519-675-7523 Fax: 519-663-9581 www.healthunit.com POST EXPOSURE MANAGEMENT: HEPATITIS B, HEPATITIS

More information

POST-EXPOSURE PROPHYLAXIS (HIV, HEP B, HEP C)

POST-EXPOSURE PROPHYLAXIS (HIV, HEP B, HEP C) POST-EXPOSURE PROPHYLAXIS (HIV, HEP B, HEP C) www.hiv-druginteractions.org No major changes to this protocol since last reviewed in 2014 Reference should also be made to the NHSGGC document on management

More information

Patient Information Sheet

Patient Information Sheet Healthcare Worker exposure to a patient s blood What is a healthcare worker exposure? Patient Information Sheet Occasionally, health care workers come into contact with the blood or body fluids of their

More information

Title: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11

Title: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11 Title: Post Exposure Prophylaxis Page 1 of 8 OBJECTIVE To standardize medical care following a Blood or Bodily Fluid Exposure (BBFE). SCOPE All Exposed Individuals (as defined below) who present for post-exposure

More information

HIV. Looking after your sexual health

HIV. Looking after your sexual health HIV Looking after your sexual health 2 HIV HIV stands for Human Immunodeficiency Virus. Once someone is infected with HIV the virus will remain in their body for the rest of their life. There is currently

More information

Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013

Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved

More information

Guidelines for Nurse Led HIV Clinic

Guidelines for Nurse Led HIV Clinic Guidelines for Nurse Led HIV Clinic Produced and approved by (Committee and Date) Kieran Sharkey Ratified by (Committee and Date) Reviewed Review date: Guidelines for Nurse Led HIV Clinic Introduction

More information

HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline

HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...

More information

July 3, 2015. III. VA policy:

July 3, 2015. III. VA policy: Antiretroviral Postexposure Prophylaxis After Sexual, Injection- Drug Use, or Other Nonoccupational Exposure to HIV (nonoccupational post- exposure prophylaxis [npep]) VA Greater Los Angeles Healthcare

More information

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral

More information

Increase of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection?

Increase of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection? Increase of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection? S. Manzanares-Laya 1, P. García de Olalla 1,2, C. Garriga 1,3,

More information

Appendix 3 Exposure Incident Report Form

Appendix 3 Exposure Incident Report Form Appendix 3 Exposure Incident Report Form January, 2015 Page 1 of 6 Please see the following pages for the Exposure Incident Report Form. Guidelines for the Management of Exposure to Blood and Body Fluids

More information

Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV. National Guidelines

Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV. National Guidelines Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV National Guidelines National guidelines for post-exposure prophylaxis after non-occupational and occupational exposure

More information

ABI Consumer Guide for gay men on HIV and Life Insurance

ABI Consumer Guide for gay men on HIV and Life Insurance ABI Consumer Guide for gay men on HIV and Life Insurance In October 2005, the insurance industry implemented a new Statement of Best Practice on HIV and Insurance. Produced by the Association of British

More information

Protocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices

Protocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices Protocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices Procedures to be followed by physicians for needle stick incidents to medical students rotating through

More information

Didactic Series. Updated Post-Exposure Prophylaxis (PEP) Guidelines. Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014

Didactic Series. Updated Post-Exposure Prophylaxis (PEP) Guidelines. Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014 Didactic Series Updated Post-Exposure Prophylaxis (PEP) Guidelines Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014 ACCREDITATION STATEMENT: University of California, San Diego School of

More information

Integrated Post-exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids

Integrated Post-exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids Integrated Post-exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids MARCH 2009 COMMUNICABLE DISEASE CONTROL Integrated Post-exposure Protocol for HIV, HBV

More information

Stefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA

Stefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA Stefan R. Rowniak, PhD, RN, MS, FNP EDUCATION 2010 2010 1991 1985 1979 1976 SF State University Seattle University Seattle, WA University of Washington Seattle, WA Post-Doctoral Student PhD, Nursing MSN,

More information

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH

More information

How testing and treatment can stop HIV. Information for gay and bisexual men.

How testing and treatment can stop HIV. Information for gay and bisexual men. How testing and treatment can stop HIV. Information for gay and bisexual men. How testing and treatment can stop HIV. Information for gay and bisexual men. We re living in a new era. We now know for sure:

More information

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) XI. OCCUPATIONAL EXPOSURES TO HEPATITIS B AND C RECOMMENDATION: When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) The risk of transmission

More information

Offering HIV Post-Exposure Prophylaxis (PEP) Following Non-Occupational Exposures

Offering HIV Post-Exposure Prophylaxis (PEP) Following Non-Occupational Exposures Offering HIV Post-Exposure Prophylaxis (PEP) Following Non-Occupational Exposures Recommendations for Health Care Providers in the State of California Arnold Schwarzenegger Governor State of California

More information

Belgian development agency

Belgian development agency Belgian development agency AIDS WHAT YOU SHOULD KNOW KEY PRINCIPLES Respect Respect yourself and others. Testing Do not wait until tomorrow. Adherence Adhere to treatment and enjoy a long and happy life.

More information

TOOLS, TRENDS AND NEW TECHNOLOGIES IN HIV PREVENTION

TOOLS, TRENDS AND NEW TECHNOLOGIES IN HIV PREVENTION TOOLS, TRENDS AND NEW TECHNOLOGIES IN HIV PREVENTION Introduction In recent years, prevention has moved to the top of the global HIV and AIDS agenda. Michel Sidibé, Executive Director of UNAIDS, recently

More information

Postexposure Prophylaxis (PEP)

Postexposure Prophylaxis (PEP) NORTHWEST AIDS EDUCATION AND TRAINING CENTER Postexposure Prophylaxis (PEP) Hillary Liss, MD Clinical Assistant Professor of Medicine, University of Washington Medical Program Director, NW AETC Last Updated:

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Multiple Sclerosis Agents

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Multiple Sclerosis Agents MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Multiple Sclerosis Agents A. Prescriptions That Require Prior Authorization Prescriptions

More information

AAB 2013 Annual Meeting & Educational Conference

AAB 2013 Annual Meeting & Educational Conference American Association of Bioanalysts AAB 2013 Annual Meeting & Educational Conference Occult Hepatitis and HIV Prophylaxis Thursday, May 16, 2013, 9:45 a.m. John H. Hughes, Ph.D. Dept Molecular Virology,

More information

Estimates of New HIV Infections in the United States

Estimates of New HIV Infections in the United States Estimates of New HIV Infections in the United States Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new HIV infections has historically

More information

Instructions for Abroad Clinical Rotation

Instructions for Abroad Clinical Rotation Revised 7/12 Instructions for Abroad Clinical Rotation While travelling abroad you may have limited access to medical care. These instructions help prepare you for a blood/ body fluid exposure. Timely

More information

Non-Academic Program Assessment Form Assessment Cycle: 2010-2011

Non-Academic Program Assessment Form Assessment Cycle: 2010-2011 College/Division Head: P.Rault, Ph.D Goal 1. Student Health Services (SHS) will support students in their growth and development. Objective 1.1. Provide quality primary care to students in a medical facility

More information

UWHC GME Global Health Emergency Plan

UWHC GME Global Health Emergency Plan UWHC GME Global Health Emergency Plan Purpose: The purpose of the Global Health Emergency Plan is to identify the appropriate procedure in the event that an emergency occurs involving a resident participating

More information

Guidelines for Blood borne Pathogen Exposure and Post Exposure Prophylaxis at Global Health Field Sites

Guidelines for Blood borne Pathogen Exposure and Post Exposure Prophylaxis at Global Health Field Sites Guidelines for Blood borne Pathogen Exposure and Post Exposure Prophylaxis at Global Health Field Sites Developed by Dr. Brian Jack and colleagues at Boston University Adapted with permission by Dr. Chad

More information

Needle-Stick Policy. http://www.utdallas.edu/ehs

Needle-Stick Policy. http://www.utdallas.edu/ehs Needle-Stick Policy Department of Environmental Health and Safety 800 West Campbell Rd., SG10 Richardson, TX 75080-3021 Phone 972-883-2381/4111 Fax 972-883-6115 http://www.utdallas.edu/ehs Modified: May

More information

SPECIALTY PROVIDER MANUAL

SPECIALTY PROVIDER MANUAL New York State Department of Health AIDS INSTITUTE Uninsured Care Programs Pre- Exposure Prophylaxis Assistance Program (PrEP-AP) SPECIALTY PROVIDER MANUAL 518-459-1641 EMPIRE STATION P.O. BOX 2052 ALBANY,

More information

HIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres

HIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres , ORIGINAL ARTICLE HIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres M N Fauziah, MD, S Anita, MD, B N Sha'ari, MD, B I RosH, MD Introduction HIV infection and AlDS is a major

More information

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL) PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)

More information

Q and A for PARTNER Studies: Interim analysis results presented at CROI 2014. CROI presentation can be found at www.chip.dk

Q and A for PARTNER Studies: Interim analysis results presented at CROI 2014. CROI presentation can be found at www.chip.dk Q and A for PARTNER Studies: Interim analysis results presented at CROI 2014 STATUS: Results embargoed until 4 March 2014, 18:30 Central European Time (CET). CROI presentation can be found at www.chip.dk

More information

Condoms for the prevention of HIV and STI transmission

Condoms for the prevention of HIV and STI transmission FACTSHEET Condoms for the prevention of HIV and STI transmission Summary Condoms are physical barriers that can reduce the risk of a sexual exposure to HIV and sexually transmitted infections (STIs). They

More information

HIV/AIDS: General Information & Testing in the Emergency Department

HIV/AIDS: General Information & Testing in the Emergency Department What Is HIV? HIV/AIDS: General Information & Testing in the Emergency Department HIV is the common name for the Human Immunodeficiency Virus. HIV is a retrovirus. This means it can enter the body s own

More information

HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014

HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014 To protect, promote and improve the health of all people in Florida through integrated state, county, and community efforts. HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida,

More information

Transcending Barriers for Safer Pleasure

Transcending Barriers for Safer Pleasure March 2016 PrEP Pre-Exposure Prophylaxis Transcending Barriers for Safer Pleasure a publication for transgender women Table of contents 1 2 5 6 7 8 9 10 10 11 12 13 14 15 16 17 18 19 20 Using this booklet...

More information

UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE

UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE UNAIDS 214 LESOTHO HIV EPIDEMIC PROFILE 214 LESOTHO Overview The Kingdom of Lesotho is landlocked and surrounded by South Africa. It has a surface area of 3 355 square kilometres and its population is

More information

Hepatitis A/B Vaccination of inmates in the Los Angeles County Jail

Hepatitis A/B Vaccination of inmates in the Los Angeles County Jail Hepatitis A/B Vaccination of inmates in the Los Angeles County Jail Garrett Cox, MPH Epidemiologist, Infection Control & Epidemiology Los Angeles County Sheriff s Department Information about LASD Jail

More information

Module 7: The Role of the Nurse

Module 7: The Role of the Nurse Module 7: The Role of the Nurse Module Objectives To describe the dynamic role of the nurse in the holistic care of a patient receiving ARV treatment To equip nurses with a sense of importance and belief

More information

WISCONSIN AIDS/HIV PROGRAM NOTES

WISCONSIN AIDS/HIV PROGRAM NOTES Wisconsin 2014 HIV Care Continuum: Statewide and Select Population Groups Casey Schumann, MS, AIDS/HIV Program Epidemiologist, AIDS/HIV Program, Wisconsin Division of Public Health Background The HIV care

More information

UK Guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure (PEPSE)

UK Guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure (PEPSE) UK Guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure (PEPSE) 0 0 0 Guideline working group: Martin Fisher Chair of writing group, late Professor of HIV medicine at Brighton

More information

Post-Exposure Prophylaxis (PEP) Guidelines for children and adolescents potentially exposed to blood-borne viruses

Post-Exposure Prophylaxis (PEP) Guidelines for children and adolescents potentially exposed to blood-borne viruses Post-Exposure Prophylaxis (PEP) Guidelines for children and adolescents potentially exposed to blood-borne viruses Authors: C Foster, G Tudor-Williams, A Bamford Date reviewed: June 2015 Next review date:

More information

Therapeutic Guidelines. Accidental exposure guidelines

Therapeutic Guidelines. Accidental exposure guidelines Therapeutic Guidelines Accidental exposure guidelines As of February 2009 Management of Accidental Exposure to HIV Counseling should be offered to all persons experiencing an exposure event. If there is

More information

(C) Deep injury and those caused by hollow bore needles, where more potential transference of blood is involved.

(C) Deep injury and those caused by hollow bore needles, where more potential transference of blood is involved. PROLOGUE The use of ARVs for post exposure prophylaxis following occupational exposure to HIV has raised different areas of uncertainty for policy makers and healthcare workers. The Ministry of Health

More information

Instructions for Clinical Rotation Abroad

Instructions for Clinical Rotation Abroad [Type text] Revised 6/13 Instructions for Clinical Rotation Abroad While travelling abroad you may have limited access to medical care. These instructions help prepare you for a blood/ body fluid exposure.

More information

Clinical Infectious Diseases Advance Access published September 1, 2015

Clinical Infectious Diseases Advance Access published September 1, 2015 Clinical Infectious Diseases Advance Access published September 1, 2015 1 No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting Jonathan E. Volk 1, Julia

More information

UNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS

UNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS I. Purpose and Definition UNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS The purpose of this policy is to delineate the management of incidents of exposure

More information

HIV, Hepatitis B, Hepatitis C and Sexually Transmitted Infections

HIV, Hepatitis B, Hepatitis C and Sexually Transmitted Infections Alberta Guidelines for Non-Occupational, Occupational and Mandatory Testing and Disclosure Act Post-Exposure Management and Prophylaxis: HIV, Hepatitis B, Hepatitis C and Sexually Transmitted Infections

More information

04/06/2015. Aaron V. Sapp, MD, MBA University of Missouri Columbia Student Health Center

04/06/2015. Aaron V. Sapp, MD, MBA University of Missouri Columbia Student Health Center Aaron V. Sapp, MD, MBA University of Missouri Columbia Student Health Center 1 Men Women 20.6% Talked to doctor 18.2% Talked to doctor 79.4% Did not talk to doctor 81.8% Did not talk to doctor Lack of

More information

Guidelines for Viral Hepatitis CTR Services

Guidelines for Viral Hepatitis CTR Services Guidelines for Viral Hepatitis CTR Services During the 2007 North Dakota Legislative Assembly, legislation that called for the creation of a viral hepatitis program was introduced and approved. The North

More information

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING MARCH 2014 A Quick Guide to POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING HIV PROVIDER REFERENCE SERIES A PUBLICATION OF THE MOUNTAIN PLAINS AIDS EDUCATION AND TRAINING CENTER MountainPlains AIDS

More information

The Basics of Drug Resistance:

The Basics of Drug Resistance: CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?

More information

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should

More information

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy Policy Statement The accelerated four-dose schedule for combined hepatitis A and B vaccine

More information

How To Improve Health Care For An Hiv Patient

How To Improve Health Care For An Hiv Patient The Role of the Nurse Practitioner in HIV Care The Three Bridges Shared Care Model Goals of the HIV Shared Care Program To improve access to primary HIV care for difficult to reach populations To demonstrate

More information

Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States

Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States Recommendations and Reports January 21, 2005 / 54(RR02);1-20 Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States Recommendations

More information

Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session.

Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session. Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* ABOUT THIS ACTIVITY Time: 60 minutes Objectives: By the end of this session, participants will be able to: Reviewed their knowledge of HIV/AIDS

More information

CRISP1 Data Archive. The NIDDK Repository offers the following three data packages from the CRISP1 study:

CRISP1 Data Archive. The NIDDK Repository offers the following three data packages from the CRISP1 study: CRISP1 Data Archive The NIDDK Repository offers the following three data packages from the CRISP1 study: 1. The standard data archive, which contains a dataset compiled by the Data Center, Center for Research

More information

Guidelines for. Blood-borne Pathogen Exposure and Post-Exposure Prophylaxis in Global Health Field Sites

Guidelines for. Blood-borne Pathogen Exposure and Post-Exposure Prophylaxis in Global Health Field Sites UW Global Health Institute Guidelines for Blood-borne Pathogen Exposure and Post-Exposure Prophylaxis in Global Health Field Sites Developed by Dr. Brian Jack and colleagues at Boston University Adapted

More information

HIV Prophylaxis For Adults After Sexual Assault. Recommendations for Health Care Providers

HIV Prophylaxis For Adults After Sexual Assault. Recommendations for Health Care Providers HIV Prophylaxis For Adults After Sexual Assault Recommendations for Health Care Providers Developed by: Oregon Attorney General s Sexual Assault Task Force and Oregon Health Authority HIV Prevention Program

More information

OHIO ATTORNEY GENERAL SEXUAL ASSAULT FORENSIC EXAMINATION (SAFE) PROGRAM INSTRUCTIONS FOR REIMBURSEMENT FORM

OHIO ATTORNEY GENERAL SEXUAL ASSAULT FORENSIC EXAMINATION (SAFE) PROGRAM INSTRUCTIONS FOR REIMBURSEMENT FORM OHIO ATTORNEY GENERAL SEXUAL ASSAULT FORENSIC EXAMINATION (SAFE) PROGRAM INSTRUCTIONS FOR REIMBURSEMENT FORM All exams must be conducted using the 2011 Ohio Sexual Assault Protocol for Sexual Assault Forensic

More information

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf

More information

The Epidemiology of Internet Sex Partnering and Intervention Use, California

The Epidemiology of Internet Sex Partnering and Intervention Use, California The Epidemiology of Internet Sex Partnering and Intervention Use, California Jeffrey D. Klausner, MD, MPH Director, STD Prevention and Control Services San Francisco Department of Public Health Associate

More information

A publication for men who have sex with men. Is taking PrEP the right choice for you? your life matters

A publication for men who have sex with men. Is taking PrEP the right choice for you? your life matters A publication for men who have sex with men Pre-exposure Prophylaxis Is taking PrEP the right choice for you? your life matters MAY 2015 Check out our four videos on PrEP as well! an overview of PrEP how

More information

BLOOD AND BODY FLUID EXPOSURE MANAGEMENT TOOL

BLOOD AND BODY FLUID EXPOSURE MANAGEMENT TOOL 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2400 Fax 604.707.2401 www.bccdc.ca Clinical Prevention Services Tel 604.707.5600 Fax 604.707.5604 www.smartsexresource.com BLOOD AND BODY FLUID EXPOSURE

More information

Frequently Asked Questions (FAQs)

Frequently Asked Questions (FAQs) Frequently Asked Questions (FAQs) Research Rationale 1. What does PrEP stand for? There is scientific evidence that antiretroviral (anti-hiv) medications may be able to play an important role in reducing

More information

Understanding the HIV Care Continuum

Understanding the HIV Care Continuum Understanding the HIV Care Continuum Overview Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the health of people living with HIV, but also dramatically lowers

More information

United States Department of Justice. Best Practices Guide to Reform HIV Specific Criminal Laws to Align with Scientifically Supported Factors

United States Department of Justice. Best Practices Guide to Reform HIV Specific Criminal Laws to Align with Scientifically Supported Factors U.S. Department of Justice Civil Rights Division United States Department of Justice Civil Rights Division Best Practices Guide to Reform HIV Specific Criminal Laws to Align with Scientifically Supported

More information

HIV futures six Making Positive Women s Lives Count

HIV futures six Making Positive Women s Lives Count archsf HIV futures six Making Positive Women s Lives Count Rachel Koelmeyer Karalyn McDonald Marian Pitts Jeffrey Grierson ABOUT THE SURVEY The HIV Futures research program is the largest of its kind in

More information

Quick Guide. For Clinicians. Based on TIP 37 Substance Abuse Treatment For Persons With HIV/AIDS

Quick Guide. For Clinicians. Based on TIP 37 Substance Abuse Treatment For Persons With HIV/AIDS Quick Guide For Clinicians Based on TIP 37 Substance Abuse Treatment For Persons With HIV/AIDS Contents Why a Quick Guide?................ 2 What Is a TIP?.................... 3 Introduction......................

More information

SHARPS INJURY POLICY

SHARPS INJURY POLICY INFECTION PREVENTION AND CONTROL SHARPS INJURY POLICY MANAGEMENT OF EXPOSURE TO BLOOD BORNE VIRUSES HIV POST EXPOSURE PROPHYLAXIS Read in conjunction with: Policy for safe handling and disposal of sharps

More information

Assertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia

Assertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia Assertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia Peter Higgs, Nyree Chung, Shelley Cogger, Rebecca Winter, Margaret Hellard & Paul Dietze Acknowledgements

More information

The Role of New Media on Sexual Health

The Role of New Media on Sexual Health The Sexual Health of Gay Men and Other MSM: HIV/STD Prevention Plus Conference The Fenway Institute, Boston MA April 26-27, 2010 The Role of New Media on Sexual Health David S. Novak, MSW, CAS Senior Public

More information

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC HIV What are HIV and AIDS? HIV stands for Human Immunodeficiency Virus. This is the virus that causes AIDS. HIV is

More information

Chlamydia THE FACTS. How do people get Chlamydia?

Chlamydia THE FACTS. How do people get Chlamydia? What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for

More information

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE

More information

Burton Hospitals NHS Foundation Trust. Corporate / Directorate. Clinical / Non Clinical. Department Responsible for Review:

Burton Hospitals NHS Foundation Trust. Corporate / Directorate. Clinical / Non Clinical. Department Responsible for Review: POLICY DOCUMENT Burton Hospitals NHS Foundation Trust Approved by: INOCULATION / SHARPS INJURY POLICY Clinical Management Board On: 13 February 2014 Review Date: January 2017 Corporate / Directorate Clinical

More information